Fig. 3.

SF-36 domain scores

Age and gender matched normative values are shown (blue). The study was not designed to compare active treatment groups. P-values from least squares mean difference comparisons active vs placebo. *P ≤ 0.05; ^¥P ≤ 0.005; †P ≤ 0.001. Green, week 12; red, week 24. BP: bodily pain; GH: general health; IXEQ4W/Q2W: ixekizumab every 4 or 2 weeks; MH: mental health; norm: normative values; PF: physical functioning; RE: role emotional; RP: role physical; SF: social functioning; SF-36: 36-item short form health survey; VT: vitality; W12: week 12; W24: week 24.